Le Lézard
Classified in: Health, Covid-19 virus
Subject: POL

ACEP Rebuts President Trump's False Statements about Overcounting COVID-19 Deaths


WASHINGTON, Oct. 25, 2020 /PRNewswire/ -- In response to President Trump's baseless claims about physicians miscounting deaths due to COVID-19, the American College of Emergency Physicians (ACEP) released the following statement:

"On behalf of the nation's emergency physicians, ACEP is appalled by President Trump's reckless and false assertions that physicians are overcounting deaths related to COVID-19. Emergency physicians and other health care workers have risked their lives day in and day out for almost a year battling the greatest public health crisis in a generation?all while watching countless patients die alone, going to work without sufficient protection equipment, and struggling with crushing anxiety about getting sick or spreading the virus to their loved ones.  

To imply that emergency physicians would inflate the number of deaths from this pandemic to gain financially is offensive, especially as many are actually under unprecedented financial strain as they continue to bear the brunt of COVID-19. These baseless claims not only do a disservice to our health care heroes but promulgate the dangerous wave of misinformation which continues to hinder our nation's efforts to get the pandemic under control and allow our nation to return to normalcy."

The American College of Emergency Physicians (ACEP) is the national medical society representing emergency medicine. Through continuing education, research, public education, and advocacy, ACEP advances emergency care on behalf of its 40,000 emergency physician members, and the more than 150 million Americans they treat on an annual basis. For more information, visit www.acep.org and www.emergencyphysicians.org.

 

 

SOURCE American College of Emergency Physicians (ACEP)


These press releases may also interest you

at 08:49
Cove Capital Investments reviews and analyzes nearly every type of asset class available for Delaware Statutory Trust investors.  This list of potential DST property asset classes includes government leased buildings, self-storage facilities,...

at 08:40
The "United States Self-Monitoring Blood Glucose Devices Market Growth, Share, Size, Trends, Analysis and Forecast (2024 - 2032)" report has been added to ResearchAndMarkets.com's offering. The U.S. Self-Monitoring Blood Glucose Devices market size...

at 08:35
Arch Insurance North America (Arch), a provider of specialized insurance and risk management solutions, today unveiled its latest products available through the Arch APEX? digital platform. Participant Accident coverage is now available for child...

at 08:35
Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Vemlidy® (tenofovir alafenamide) 25 mg tablets as a once-daily treatment for chronic hepatitis B...

at 08:35
Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today reported financial...

at 08:30
Solitario Resources Corp. ("Solitario") is pleased to report that it has discovered another high-grade gold zone on its Golden Crest project, named Sleeping Beauty. Recently received assay results from reconnaissance rock sampling of...



News published on and distributed by: